The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 34

More JCP Articles

JCP
The Potential Power of Virtual Group CBT
Commentary

July 24, 2023

Rachel Vanderkruik, PhD, MSc, discusses Huh and colleagues’ study of online nurse-delivered group CBT for postpartum depression, highlighting 4 key aspects that make the intervention particularly exciting.
JCP
Therapeutic Reference Range for Olanzapine
Systematic Review

July 19, 2023

A therapeutic reference range of 20–40 ng/mL for oral and long-acting injectable olanzapine yields optimal treatment effects in schizophrenia spectrum disorders. Dose reduction is not needed above 40 ng/mL…
, , , et al
JCP
Inflammatory Features in Prodromal Psychosis
Original Research

July 17, 2023

This study suggests that niacin response tests should be considered in early psychosis identification and prediction.
, , , et al
JCP
Tonic Immobility and Peritraumatic Dissociation in PTSD
Original Research

July 12, 2023

Tonic immobility and peritraumatic dissociation in reaction to trauma are associated with later psychopathology. This study suggests that interventions targeting these reactions could reduce future PTSD risk.
,
JCP
Safe Delivery of TMS to Patients With Implanted Devices
Letter to the Editor

July 12, 2023

Tendler et al argue that, in considering transcranial magnetic stimulation (TMS) treatment, providers should refer to recent guidelines and literature reports instead of universally excluding patients based on outdated,…
, ,
JCP
SNRIs and Hypertensive Disorders of Pregnancy
Original Research

July 10, 2023

Hypertensive disorders of pregnancy (HDP) are a major complication. In this study, the risk of HDP with SNRIs (9.5%) was significantly higher than with SSRIs (5.5%).
, , , et al
JCP
Cardiovascular Risk by SMI Subtype
Original Research

July 5, 2023

Cardiovascular disease is the leading cause of death for people with serious mental illness. A clinical decision support tool produced a significant relative reduction in total modifiable cardiovascular risk…
, , , et al
JCP
Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al
Letter to the Editor

July 3, 2023

Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.
,
JCP
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
Letter to the Editor

July 3, 2023

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.
, , , et al
JCP
Subcallosal Cingulate Gyrus Deep Brain Stimulation for TRD
Original Research

June 28, 2023

DBS targeting the subcallosal cingulate gyrus to treat depressive symptoms resulted in response and remission rates of 75% and 62.5%.
, , , et al
JCP
Vitamin D3 and Omega-3 Fatty Acids for Depression Prevention
Original Research

June 26, 2023

Although several lines of evidence suggest that vitamin D3 and omega-3 fatty acids promote mood health, neither supplement showed benefits for indicated and selective prevention of late-life depression.
, , , et al
JCP
GnRH Analogs in Premenstrual Dysphoric Disorder: Review and Practical Guideline
Systematic Review

June 21, 2023

This guideline provides screening tools, patient and provider handouts, and in-depth analysis of GnRH analogs and hormonal addback paradigms in PMDD.
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe